AZTA
Price
$30.30
Change
+$0.78 (+2.64%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
1.35B
74 days until earnings call
PACB
Price
$1.27
Change
+$0.03 (+2.42%)
Updated
Sep 5, 02:27 PM (EDT)
Capitalization
372.46M
66 days until earnings call
Interact to see
Advertisement

AZTA vs PACB

Header iconAZTA vs PACB Comparison
Open Charts AZTA vs PACBBanner chart's image
Azenta
Price$30.30
Change+$0.78 (+2.64%)
Volume$5.72K
Capitalization1.35B
Pacific Biosciences of California
Price$1.27
Change+$0.03 (+2.42%)
Volume$8.76K
Capitalization372.46M
AZTA vs PACB Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. PACB commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and PACB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (AZTA: $29.52 vs. PACB: $1.24)
Brand notoriety: AZTA and PACB are both not notable
AZTA represents the Pharmaceuticals: Other, while PACB is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 116% vs. PACB: 76%
Market capitalization -- AZTA: $1.35B vs. PACB: $372.46M
AZTA [@Pharmaceuticals: Other] is valued at $1.35B. PACB’s [@Medical/Nursing Services] market capitalization is $372.46M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whilePACB’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • PACB’s FA Score: 0 green, 5 red.
According to our system of comparison, AZTA is a better buy in the long-term than PACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while PACB’s TA Score has 2 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 5 bearish.
  • PACB’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than PACB.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -1.34% price change this week, while PACB (@Medical/Nursing Services) price change was -6.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.15%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +24.89%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

PACB is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.35B) has a higher market cap than PACB($372M). PACB YTD gains are higher at: -32.240 vs. AZTA (-40.960). AZTA has higher annual earnings (EBITDA): 11.3M vs. PACB (-112.13M). AZTA (319M) and PACB (315M) have equal amount of cash in the bank . AZTA has less debt than PACB: AZTA (52.6M) vs PACB (699M). AZTA has higher revenues than PACB: AZTA (669M) vs PACB (156M).
AZTAPACBAZTA / PACB
Capitalization1.35B372M364%
EBITDA11.3M-112.13M-10%
Gain YTD-40.960-32.240127%
P/E RatioN/AN/A-
Revenue669M156M429%
Total Cash319M315M101%
Total Debt52.6M699M8%
FUNDAMENTALS RATINGS
AZTA vs PACB: Fundamental Ratings
AZTA
PACB
OUTLOOK RATING
1..100
5959
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
6557
P/E GROWTH RATING
1..100
5578
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (70) in the Electronic Production Equipment industry is in the same range as PACB (100) in the Biotechnology industry. This means that AZTA’s stock grew similarly to PACB’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as PACB (100) in the Biotechnology industry. This means that AZTA’s stock grew similarly to PACB’s over the last 12 months.

AZTA's SMR Rating (95) in the Electronic Production Equipment industry is in the same range as PACB (100) in the Biotechnology industry. This means that AZTA’s stock grew similarly to PACB’s over the last 12 months.

PACB's Price Growth Rating (57) in the Biotechnology industry is in the same range as AZTA (65) in the Electronic Production Equipment industry. This means that PACB’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's P/E Growth Rating (55) in the Electronic Production Equipment industry is in the same range as PACB (78) in the Biotechnology industry. This means that AZTA’s stock grew similarly to PACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAPACB
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 15 days ago
71%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCSVX9.840.15
+1.55%
Geneva SMID Cap Growth Institutional
PSBPX30.980.47
+1.54%
Principal SmallCap R5
NMUEX11.370.11
+0.98%
Neuberger Berman Multi-Cap Opp E
LCEYX19.670.11
+0.56%
Invesco Diversified Dividend Y
CGRWX34.010.18
+0.53%
Invesco Comstock Select A

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with MTD. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+0.51%
MTD - AZTA
65%
Loosely correlated
+1.51%
RVTY - AZTA
64%
Loosely correlated
+2.81%
A - AZTA
64%
Loosely correlated
+2.60%
BRKR - AZTA
59%
Loosely correlated
+1.50%
TMO - AZTA
59%
Loosely correlated
+1.02%
More

PACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PACB has been loosely correlated with LAB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PACB
1D Price
Change %
PACB100%
-1.59%
LAB - PACB
50%
Loosely correlated
N/A
AZTA - PACB
47%
Loosely correlated
+0.51%
ILMN - PACB
46%
Loosely correlated
+1.68%
TWST - PACB
44%
Loosely correlated
-1.42%
NVST - PACB
39%
Loosely correlated
+2.36%
More